A cardiology team in Shanghai ran a rigorous double-blind randomized controlled trial across three hospitals. Nine hundred and forty patients. Eighteen months of data collection. The findings on a novel statin combination were statistically significant at p is less than 0.001 and clinically meaningful by every measure the trial protocol specified.
They submitted to The Lancet. Three weeks later: desk rejection.
The editor’s note was boilerplate. Reviewer 2 was less diplomatic: “While the clinical data are sound, the manuscript does not meet the linguistic and presentational standards expected for publication in this journal.”
The research was publication-ready in every respect except one. The team had produced a study that could shift clinical practice, and it had been turned away not because of the science, not because of the methodology, not because of the sample size or the statistical analysis or the clinical significance. It had been turned away because of the language in which the science was presented.
This is not a science problem. This is a language problem. And it is the single most preventable cause of rejection in academic medicine.
The rejection landscape: how many good papers die at the language checkpoint
Language-related rejection is not rare. It is systematic. A 2016 analysis in the Journal of Korean Medical Science found that among manuscripts submitted by non-native English-speaking researchers, approximately 35 percent received editorial rejection recommendations citing “language and presentation” as a primary or contributing factor. A subsequent study in Scientometrics (2020), examining over 2,000 submissions to clinical journals with impact factors above five, found that manuscripts from non-Anglophone institutions were approximately 2.5 times more likely to be rejected before peer review than manuscripts from Anglophone institutions with otherwise similar methodological quality scores.
This is not evidence of bias in the simple sense. Editors are not rejecting papers because the author’s name sounds foreign. They are rejecting papers because when the language is weak, the reviewer cannot assess the science. If a reviewer cannot understand exactly what the researchers did, cannot follow the logic connecting the results to the conclusions, and cannot trust that the statistical analysis was performed as described, the reviewer cannot recommend publication. The linguistic failure becomes a scientific failure — not because the science was bad, but because the language prevented the science from being seen.
The irony is cruel: the researchers who most need international publication are often writing in their second or third language, and their manuscripts are being judged against standards designed for native speakers. The gap is not in the quality of the research. It is in the quality of the linguistic presentation. And the gap is closable.
What the AMA Manual of Style actually demands
The American Medical Association Manual of Style is the dominant reference standard for medical journals in the English-speaking world, used by JAMA, the Archives journals, and hundreds of other publications. It is the gatekeeper’s rulebook. Most non-native-English researchers have heard of it. Very few have read it.
The AMA manual is not primarily a grammar guide. It is a communication standard. Its core requirements include:
Precision of terminology. The manual is unsparing about imprecise language. “Significant” and “significance” are reserved for statistical contexts unless clearly modified. “Compliance” and “adherence” carry different implications for medication studies. “Mortality” and “fatality” are not interchangeable. A manuscript that uses any of these terms loosely will be flagged by an experienced editor within the first three paragraphs.
Structural integrity of the IMRAD format. Introduction, Methods, Results, and Discussion form the backbone of clinical research reporting. The AMA manual specifies not just the order of these sections but their internal logic. The Methods section must provide sufficient detail for exact replication. The Results section must report data without interpretation. The Discussion must interpret without restating. A common failure pattern in non-native-English manuscripts is bleeding interpretation into the Results section — a structural error that signals to the editor that the authors do not fully understand the conventions of medical reporting, even if the underlying data are sound.
Statistical reporting clarity. The AMA manual specifies how statistical results should be reported, including the distinction between reporting p-values (p = 0.032, not p
Four dimensions of medical manuscript English that non-native researchers struggle with
Dimension one: clinical verb precision — where the wrong verb changes the claim the data can support.
English medical writing operates on a hierarchy of certainty that is rigidly enforced in high-impact journals. The choice of verb determines the strength of the claim:
▶ “Demonstrate” and “prove” are reserved for definitive evidence, which most clinical studies do not produce.
▶ “Indicate,” “suggest,” and “imply” signal weaker associations.
▶ “Associate with” reports correlation. “Contribute to” implies causation. Conflating the two is one of the most common reasons a statistical reviewer will recommend rejection.
▶ “Appear to” and “seem to” introduce doubt that must be deliberate, not accidental.
Non-native manuscripts frequently use these verbs interchangeably because in many languages the gradations between them are less strictly observed or do not exist. The result is a manuscript that overclaims unintentionally. The reviewer reads a claim the authors did not mean to make, finds that the data do not support it, and recommends rejection. The authors then resubmit to a lower-impact journal with the same verb problem and get the same rejection for a different reason. The cycle repeats because the linguistic issue was never diagnosed.
Dimension two: nominalization and density — where concise becomes incomprehensible.
Medical writing in non-Anglophone research cultures often favors nominalization — the conversion of verbs into nouns — as a marker of academic seriousness. In Chinese medical writing, for example, “实施了……的检测” (literally “the implementation of detection of……”) sounds appropriately formal. A direct translation into English produces something like: “The implementation of the detection of elevated cardiac troponin levels was performed.”
This sentence is grammatically unobjectionable. It is also nearly unreadable. The AMA-compliant version is: “Troponin levels were measured.” Four words instead of thirteen. The information density has increased while the word count has decreased. The reader understands more from less.
Layering nominalizations is the fastest way to make a strong manuscript sound like it was translated through a bureaucratic memo. A professional medical editor does not just fix the grammar. They de-nominalize. They rebuild sentences around strong verbs. They strip the nominalization layer off the manuscript like peeling paint off a window — and the data underneath are suddenly visible.
Dimension three: article usage — where “a patient” and “the patient” tell different stories.
English articles create a level of meaning that does not exist in article-free languages, including Chinese, Japanese, Korean, Thai, and many Slavic languages. The difference between “a patient” and “the patient” is not decorative. It is referential.
▶ “The patient” in the Results section refers to the specific patient about whom the data are reported. “A patient” refers to patient behavior in general, which belongs in the Introduction or Discussion, not the Results.
▶ Misusing articles in the Methods section can make it unclear whether a procedure was performed once on one patient or routinely on all patients. A sentence like “Patient underwent echocardiography” is ambiguous: which patient? All patients? The index patient? The reviewer cannot tell.
▶ The absence of articles is one of the first things a reviewer’s eye catches. It signals non-native writing immediately, and once that signal is received, the reviewer reads the rest of the manuscript with heightened skepticism.
Dimension four: hedging appropriately — where confidence and caution must coexist.
High-impact medical journals reward appropriate hedging. The authors must claim what the data can support and no more. This requires a set of linguistic devices that non-native writers consistently underuse: modal verbs (may, might, could), softening constructions (it is possible that, to the extent that), and limiting phrases (within the constraints of this study, based on the available evidence).
A non-native manuscript that states “This treatment reduces mortality” is making an absolute claim. Reweighted to AMA standards, the same sentence becomes “These findings suggest that this treatment may be associated with a reduction in all-cause mortality, although further confirmatory studies are required.” The data are the same. The claim is the same. The language makes the difference between a manuscript that overstates and a manuscript that responsibly reports. Top journals demand the latter. Weak manuscripts default to the former because the authors do not have the linguistic toolkit to calibrate the distinction.
Before and after: a paragraph transformed
Here is an actual paragraph from a rejected manuscript. Cardiology. Chinese principal investigator. Submitted to Circulation.
Before:
“The implementation of the administration of the novel anticoagulant protocol was conducted among 340 participants who have underwent percutaneous coronary intervention in the period from January 2021 to June 2022. The occurrence of major adverse cardiovascular events was observed to be decreased in the experimental group compared with the control group, this difference was statistical significant (p less than 0.05).”
After:
“We enrolled 340 patients who underwent percutaneous coronary intervention between January 2021 and June 2022 and randomly assigned them to receive either the novel anticoagulant protocol or standard care. The incidence of major adverse cardiovascular events was lower in the experimental group than in the control group (12.4% vs. 19.7%; hazard ratio, 0.61; 95% CI, 0.42 to 0.88; p = 0.008).”
The difference:
▶ “Implementation of the administration of the protocol was conducted” → “We assigned them to receive.” The nominalization stack is gone. A subject appears (the researchers). A verb appears (assigned). The reader knows who did what.
▶ “Was observed to be decreased” → “was lower.” The measurement is reported directly, not through a lens.
▶ “Statistical significant” → “p = 0.008.” The exact value replaces the threshold notation.
▶ Effect size and confidence interval are now included. The original paragraph gave the reviewer a p-value and nothing else. The revised paragraph gives the reviewer everything they need to assess the clinical significance independently.
The original paragraph represented data that were collected over eighteen months by a team of twelve researchers at three hospitals. The revised paragraph represents the same data. The difference is that the revised paragraph is publishable.
The peer review filter: what actually happens to language-weak manuscripts
To understand why language editing matters, it helps to understand the numbers inside the editorial office.
A top-tier medical journal like The Lancet receives approximately 8,000–10,000 submissions per year and publishes approximately 5–7 percent of them. The journal’s editorial staff is small. The desk rejection rate is high. An editor who must triage twenty submissions in a morning has minutes per manuscript to decide whether it advances to peer review.
In that environment, a manuscript that is methodologically sound but linguistically weak is almost certain to be desk-rejected. The editor does not have time to decode what the authors meant. The editor has time to read the abstract, scan the key tables, and decide. If the language gets in the way of that scan, the manuscript is declined. The reviewers never see it. The data never reach the audience they were collected for.
The solution is not for researchers to become native English speakers. That is impossible on demand and unreasonable as an expectation. The solution is to treat language editing as a required step in the publication process — as routine as the statistical review, as non-negotiable as the ethics committee approval. A manuscript that has been professionally edited by a medical-language specialist has a significantly higher probability of surviving desk review, regardless of the authors’ native language.
What professional medical manuscript editing actually delivers
This is not proofreading. Proofreading catches spelling errors and missing commas. Professional medical editing operates at the level of argument structure, disciplinary convention, and publishability. Here is what it includes:
1. AMA Manual compliance. Every citation format, every statistical notation, every abbreviation protocol, every table and figure format is brought into conformity with the target journal’s style guide. For most journals that accept clinical research, this means AMA compliance. The editor knows the manual. The researcher should not need to.
2. Clinical language recalibration. The editor rebuilds sentences to use active voice where the original used passive. The editor replaces nominalization stacks with strong verbs. The editor calibrates hedging to match what the data can support. The editor ensures terminology is used with clinical precision, not approximate dictionary equivalence.
3. Argument structure audit. The editor verifies that the Introduction builds a case, that the Methods section would permit replication, that the Results section reports without interpreting, and that the Discussion interprets without restating. A structural problem in the IMRAD framework is the single fastest route to peer-review rejection. The editor catches these problems before the journal does.
4. Statistical reporting verification. The editor flags statistical reporting that does not meet journal standards: p-values reported as thresholds instead of exact values, missing confidence intervals, missing test specifications, inconsistent decimal precision. The editor does not recalculate the statistics. The editor ensures that what the authors calculated is what the manuscript reports, in the format the journal expects.
5. Ethical and regulatory consistency. The editor verifies that the ethics statement, conflict-of-interest disclosures, clinical trial registration number, data availability statement, and funding acknowledgments are present, correctly formatted, and internally consistent. Missing or malformed disclosures are a frequent cause of administrative rejection that has nothing to do with the science.
6. Cover letter and response-to-reviewers drafting. A well-written cover letter that frames the manuscript’s contribution for the editor is a submission advantage that costs nothing but time. A professionally structured response to reviewer comments — organized, respectful, addressing every point in order — can rescue a manuscript that received a revise-and-resubmit decision. Both documents are part of the submission package and both benefit from professional editing.
The cost of not editing: one rejection cascade, traced
Let me trace what actually happens to a strong study with weak language, because researchers routinely underestimate the compound cost.
▶ Submission one: The Lancet. Desk rejection, three weeks. Language cited.
▶ Reformatted minimally. Submission two: JAMA. Desk rejection, four weeks. No specific reason, but the language has not changed.
▶ Submission three: BMJ. Sent to peer review. Reviewers flag the language as an obstacle to assessing the methods. Major revision requested. The team revises, resubmits. Five months from first submission now.
▶ Rejection after revision. The language is still not at the standard the journal expects.
▶ Submission four: a respectable specialty journal, impact factor 4.7. Accepted. Eleven months from first submission.
The accepted journal’s impact factor is approximately one-tenth of the journal the data were originally intended for. The findings that could have influenced international clinical guidelines are now in a journal that most guideline committees will not systematically review. The publication exists. The impact does not.
The cost of professional editing, across this entire cascade, would have been approximately $800–$1,500. The cost of not editing was the difference between The Lancet and an impact factor 4.7 specialty journal. That is not a cost that appears on any balance sheet. It is real.
Artlangs Translation provides professional medical manuscript editing for clinical researchers submitting to international journals: AMA Manual and ICMJE-compliant formatting, clinical language recalibration, IMRAD structural audit, statistical reporting verification, and cover letter/response-to-reviewers drafting. Every editor assigned to a medical manuscript has subject-matter training in clinical research methodology and experience with manuscripts accepted at journals in the Lancet, JAMA, BMJ, and NEJM families. 230+ language pairs. Your data deserves the journal it was collected for. The language should not be the reason it does not get there.
